Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
SYNAGEVA BIOPHARMA CORP
| Metric | SYNAGEVA BIOPHARMA CORP Healthcare |
|---|---|
| Quality Score | 27 / 100 |
| Revenue (latest) | $2M |
| Net income (latest) | −$36M |
| Operating margin | −2299.9% |
| Net margin | −2296.6% |
| Return on equity | −7.7% |
| Return on assets | −7.2% |
| Return on capital (ROCE) | −7.6% |
| Debt / equity | 0.07× |
| Revenue growth (YoY) | −69.0% |
| Altman Z″ (distress) | 18.30 |
| Accruals / assets | 22.6% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.